The increased expression of CCR9 and α4β7 on CD161+ T cells from blood as well as the ability of these cells to respond to RA to a greater degree than CD161− T cells suggests that these cells may have received a RA signal during T cell priming, either in the gut or the periphery, which resulted in gut homing. Here, CCR9 is linked to rheumatoid arthritis.